Clinical trials - Press Releases

Date	Title	Company
16-Jul-2021	Digital X-ray Market:Emerging Trends and Developments	MarketsandMarkets Research Private Ltd.
16-Jul-2021	Breath Analyzer Market worth $1,167 million - Technological Advancements and Asia-Pacific to witness the highest growth rate	MarketsandMarkets Research Private Ltd.
16-Jul-2021	Increasing Adoption of Spatial Genomics Techniques for Drug Discovery - Spatial Genomics Market Development	Markets and Markets
16-Jul-2021	Cold Pain Therapy Market worth $2.0 billion – Growing Number of Hip and Sports Injuries across the Globe	MarketsandMarkets Research Private Ltd.
16-Jul-2021	Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prevention trial of donanemab	Lilly and Banner Alzheimer's Institute
16-Jul-2021	Generic Medicine Market Report Covers Future Trends With Research 2021-2027 \| Teva, Novartis, Pfizer, Sun Pharmaceutical, Mylan.	Axel Reports
15-Jul-2021	Oligonucleotide Synthesis Market: Growing Investments in Synthetic Biology and Genome Fields	MarketsandMarkets Research Private Ltd.
15-Jul-2021	Analysis of Consultancy Services Booming in Healthcare Industry	MarketsandMarkets Research Private Ltd.
15-Jul-2021	uMotif and Xperiome collaborate to bring studies to rare disease patients more quickly and effectively	Xperiome
15-Jul-2021	Premier of South Australia Launches $1.5m Vaccine and Immunobiology State-of-the art Laboratory for APAC Clinical Trials	Agilex Biolabs
13-Jul-2021	Exclusive Interview Released: Richard Denk, SKAN AG: Co-chair and speaker at SMi’s Aseptic Processing Conference	SMi Group
13-Jul-2021	Breakthrough EMPEROR-Preserved phase 3 trial for empagliflozin (Jardiance®) meets primary end point and demonstrates benefit in patients with heart failure with preserved ejection fraction (HFpEF)	Boehringer Ingelheim and Eli Lilly and Company
13-Jul-2021	Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus Infection	Arbutus Biopharma
13-Jul-2021	Tezepelumab is the first and only biologic to consistently and significantly reduce asthma exacerbations in a broad population across Phase II and III clinical trials	AstraZeneca
13-Jul-2021	Immutep receives FDA and IRB approval in the US for Phase IIb TACTI-003 trial in HNSCC	Immutep
13-Jul-2021	Panthera steps up its move into oncology trials with more than 12 trials in the pipeline and a prostate trial underway	Panthera
13-Jul-2021	Enterome announces first patient dosed in a Phase 1/2 trial with second OncoMimicsTM vaccine, EO2463, in non-Hodgkin lymphoma	ENTEROME SA
13-Jul-2021	Valo Therapeutics Announces Clinical Trial Application Submission for German Phase I Oncology Clinical Trial of PeptiCRAd-1 with Pembrolizumab	Valo Therapeutics
13-Jul-2021	Digital PCR Market Top Segments and Future Trends	Markets and Markets
13-Jul-2021	Multiple Patients Dosed in Topical Phase I/II Clinical Trial	Recce Pharmaceuticals